BIO14414-T1

Apelin for the treatment of type 2 diabetes

Use of Apelin in humans has a positive effect on insulin sensitivity with a good tolerance and a good safety. Thus, a first object of the invention relates to an APJ receptor agonist for use in the treatment or the prevention of diabetes.(Eur J Pharmacol. 2015 Sep 15;763(Pt B):149-59. doi: 10.1016/j.ejphar.2015.05.017. Review.)


Keywords : Apelin, APJ receptor
Patent Application number : EP15305422.6
Patent Application date : 2015-03-25
Multidisciplinary field : -
Technology/Engineering : -
Technological Platform : -
Rare disease : -
Second indication : -
Inventors : Isabelle CASTAN-LAURELL
Laurent CAZALS
Philippe VALET
Pierre GOURDY
Publications :
  • Eur J Pharmacol. 2015 Sep 15;763(Pt B):149-59. doi: 10.1016/j.ejphar.2015.05.017. Review.

Related offers


The 10 Last viewed

You haven't seen any form yet.